Advertisement
Screener

XBIOTECH INC. (XBIT) Patents: Active

XBIOTECH INC. Active Patents

25 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-04-03: Application 18295211; Invention True human antibody specific for interleukin 1 alpha; Applicant XBIOTECH INC.; Status Patented Case.
  • 2023-04-03: Application 18295205; Invention True human antibody specific for interleukin 1 alpha; Applicant XBIOTECH INC.; Status Patented Case.
  • 2023-04-03: Application 18295201; Invention True human antibody specific for interleukin 1 alpha; Applicant XBIOTECH INC.; Status Patented Case.
  • 2023-04-03: Application 18295193; Invention True human antibody specific for interleukin 1 alpha; Applicant XBIOTECH INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-04-0318295211True human antibody specific for interleukin 1 alphaXBIOTECH INC.Patented Case2026-02-1012545724US20230287104A1
John Simard
Sushma Shivaswamy
Galina Kuzmicheva
United States
United States
United States
HINES, JANA A
2023-04-0318295205True human antibody specific for interleukin 1 alphaXBIOTECH INC.Patented Case2026-02-1712552860US20230287103A1
John Simard
Sushma Shivaswamy
Galina Kuzmicheva
United States
United States
United States
MERTZ, PREMA MARIA
2023-04-0318295201True human antibody specific for interleukin 1 alphaXBIOTECH INC.Patented Case2026-02-0312540177US20230287102A1
John Simard
Sushma Shivaswamy
Galina Kuzmicheva
United States
United States
United States
ALLEN, MARIANNE P
2023-04-0318295193True human antibody specific for interleukin 1 alphaXBIOTECH INC.Patented Case2026-02-0312540176US20230322915A1
John Simard
Sushma Shivaswamy
Galina Kuzmicheva
United States
United States
United States
XIAO, YAN
2022-06-2117807939ARTHRITIS TREATMENTXBiotech Inc.Patented Case2024-10-1512116405US20220363750A1
John SIMARD
United States
ALLEN, MARIANNE P
2022-04-1517659466Compositions and methods for treating and preventing staphylococcus aureus infectionsXBiotech Inc.Patented Case2023-10-0311773157US20220251175A1
John Simard
United States
GRASER, JENNIFER E
2020-01-0816737841COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONSXBIOTECH INC.Patented Case2022-06-2811370831US20200131252A1
John Simard
United States
GRASER, JENNIFER E
2019-01-0716241809Compositions and methods for treating and preventing staphylococcus aureus infectionsXBiotech, Inc.Patented Case2020-03-0310577410US20190127449A1
John Simard
United States
BASKAR, PADMAVATHI
2018-12-2016228060Treatment for neoplastic diseasesXBiotech Inc.Patented Case2024-03-1911932688US20190127460A1
John Simard
United States
PAK, MICHAEL D
2017-10-1115730218Cachexia TreatmentXBiotech, Inc.Patented Case2019-02-1210202449US20180037647A1
John Simard
United States
HISSONG, BRUCE D
2017-08-1815680533Compositions and Methods for Treating and Preventing Staphylococcus Aureus InfectionsXBiotech, Inc.Patented Case2019-02-2610214581US20170349648A1
John Simard
United States
BASKAR, PADMAVATHI
2016-11-3015364597Treatment of DiabetesXBiotech, Inc.Patented Case2018-06-059988447US20170081403A1
John Simard
United States
HISSONG, BRUCE D
2016-09-3015281676Compositions and Methods for Treating and Preventing Staphylococcus Aureus InfectionsXBiotech, Inc.Patented Case2017-10-109783598US20170015734A1
John Simard
United States
BASKAR, PADMAVATHI
2016-08-2615248413IMMUNOGLOBULIN VARIABLE REGION LIBRARIESXBiotech, Inc.Patented Case2017-06-069670483US20160362679A1
John Simard
United States
BURKHART, MICHAEL D
2016-06-0615174068COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONSXBiotech, Inc.Patented Case2016-11-089486523US20160279243A1
John Simard
United States
BASKAR, PADMAVATHI
2015-11-1314940537IDENTIFYING AFFINITY-MATURED HUMAN ANTIBODIESXBiotech, Inc.Patented Case2016-07-199394536US20160060619A1
John Simard
United States
BURKHART, MICHAEL D
2015-11-1214939454IDENTIFYING AFFINITY-MATURED HUMAN ANTIBODIESXBiotech, Inc.Patented Case2016-09-279453217US20160060618A1
John Simard
United States
BURKHART, MICHAEL D
2015-10-0814877964Human Antibody Specific for Interleukin-1alphaXBiotech, Inc.Patented Case2017-12-129840558US20160024202A1
John Simard
United States
HAMUD, FOZIA M
2015-06-0314729260Compositions and Methods for Treating and Preventing Staphylococcus Aureus InfectionsXBiotech, Inc.Patented Case2016-08-169416172US20150344548A1
John Simard
United States
BASKAR, PADMAVATHI
2014-12-1114567072Human Antibody Specific for IL-1alphaXBiotech, Inc.Patented Case2015-11-109181338US20150094455A1
John Simard
United States
HAMUD, FOZIA M
2014-02-1114177892NUCLEIC ACIDS ENCODING A HUMAN MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO IL-1aXBiotech, Inc.Patented Case2015-02-178956831US20140186943A1
John Simard
United States
HAMUD, FOZIA M
2013-09-1814030561Treatment of DiabetesXBiotech, Inc.Patented Case2017-01-179545441US20140086933A1
John Simard
United States
HISSONG, BRUCE D
2013-02-1413767292METHOD FOR KILLING IL-1 ALPHA EXPRESSING CELLSXBIOTECH, INC.Patented Case2014-07-228784817US20130177982A1
John Simard
United States
HAMUD, FOZIA M
2013-02-0813762453Inhibiting Cell MigrationXBIOTECH, INC.Patented Case2014-03-258679489US20130171728A1
John Simard
United States
HAMUD, FOZIA M
2012-09-2113624004CACHEXIA TREATMENTXBIOTECH, INC.Patented Case2017-11-079809649US20130078258A1
John Simard
United States
HISSONG, BRUCE D

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95